Evotec Centogene have entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic diseases. Centogene and Evotec initiated the collaboration to develop a strategic high-throughput platform for testing novel small molecules in rare hereditary metabolic diseases. The collaboration brings together Evotec’s leading induced pluripotent stem cell (“iPSC”) platform…